Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03840200
Title A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche

fallopian tube cancer

peritoneum cancer

prostate adenocarcinoma

endometrioid ovary carcinoma

ovarian clear cell carcinoma

ovarian serous carcinoma

Her2-receptor negative breast cancer


Ipatasertib + Rucaparib

Age Groups: adult | senior
Covered Countries USA | ITA | ESP

No variant requirements are available.